Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
77,533,333
-
Total 13F shares
-
34,987,922
-
Share change
-
+18,353,557
-
Total reported value
-
$465,886,559
-
Put/Call ratio
-
121%
-
Price per share
-
$13.32
-
Number of holders
-
52
-
Value change
-
+$255,393,890
-
Number of buys
-
44
-
Number of sells
-
9
Institutional Holders of Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) as of Q1 2024
As of 31 Mar 2024,
Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,987,922 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Artal Group S.A., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), JANUS HENDERSON GROUP PLC, SILVERARC CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and Vestal Point Capital, LP.
This page lists
52
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.